Biogen Idec Inc (BIIB): Biogen Idec's CEO Presents at Morgan Stanley ... Seeking Alpha We have daclizumab in 2014 and then actually a series of Phase 1, Phase 2 readouts that are pretty important, that we can talk about some more. I think that I started with the commercial phase, but if you look at the trajectory, the journey that the ... |
